YASMIN OCULAR LIMITED
Executive Summary
Yasmin Ocular Limited, a micro-entity operating in human health activities since late 2021, exhibits concerning liquidity and solvency indicators with persistent negative net current assets and minimal equity. Despite compliance with filing requirements and stable management, the financial position suggests elevated risk for meeting obligations without further capital or operational improvements. Further financial detail and operational insight are required for a comprehensive risk assessment.
View Full Analysis Report →- Legal registered address
- Suite 3 , 2nd Floor Congress House, 14 Lyon Road Harrow Middlesex United Kingdom HA1 2EN Copied!
Latest financial results as of 30 August 2025- Current assets
- £1.70k
- Fixed assets
- £5.75k
- Current creditors
- £7.02k
- Shareholders funds
- £426
View full financial accounts- Current assets
- £1.70k
- Fixed assets
- £5.75k
- Current creditors
- £7.02k
- Shareholders funds
- £426
- Company number
- 13814710 Copied!
Accounts
Latest annual accounts were to 31 December 2023
Next annual accounts are due by 30 September 2025
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 21 December 2024
Next statement due by 4 January 2026
Nature of business (SIC)
86900 - Other human health activities
Latest company documents
| Date | Description |
|---|---|
| 30/12/2430 December 2024 | Confirmation statement made on 2024-12-21 with updates |
| 24/09/2424 September 2024 | Micro company accounts made up to 2023-12-31 |
| 31/12/2331 December 2023 | Annual accounts for year ending 31 Dec 2023 |
| 31/12/2331 December 2023 | Confirmation statement made on 2023-12-21 with no updates |
| 14/08/2314 August 2023 | Micro company accounts made up to 2022-12-31 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company